Evidence map›Paper›PMID 32363529›Full record

Trial reportDigestive diseases and sciences2021

Linked Color Imaging Can Improve Detection Rate of Early Gastric Cancer in a High-Risk Population: A Multi-Center Randomized Controlled Clinical Trial.

Jie Gao, Xiaofeng Zhang, Qianqian Meng, Hangbin Jin, Zhenhua Zhu, Zhijie Wang, Wei Qian, Luoman Zhang, Yan Liu, Min Min and 24 more

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Digestive diseases and sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Screening strategies for the early detection of non-cardia gastric cancer in low- to moderate-prevalence regions: Asia-Pacific gastroesophageal cancer congress consensus 2026.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Application Value of Antimicrobial Peptides in Gastrointestinal Tumors.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Clinical Usefulness of Linked Color Imaging for Detection and Characterization of UndifferentiatedType Early Gastric Cancer.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Article
  18. Linked Color Imaging for Stomach.Diagnostics (Basel, Switzerland) · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 16 institutions in 1 country.

Jie GaoDepartment of Gastroenterology, Changhai Hospital, The Second Military University, Shanghai, China.
Xiaofeng ZhangDepartment of Gastroenterology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qianqian MengDepartment of Gastroenterology, Changhai Hospital, The Second Military University, Shanghai, China.
Hangbin JinDepartment of Gastroenterology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhenhua ZhuThe First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhijie WangDepartment of Gastroenterology, Changhai Hospital, The Second Military University, Shanghai, China.
Wei QianDepartment of Gastroenterology, Changhai Hospital, The Second Military University, Shanghai, China.
Luoman ZhangDepartment of Gastroenterology, Changhai Hospital, The Second Military University, Shanghai, China.
Yan LiuDepartment of Gastroenterology, The Fifth Medical Centre, Chinese PLA General Hospital (Former 307th Hospital of the PLA), Beijing, China.
Min MinDepartment of Gastroenterology, The Fifth Medical Centre, Chinese PLA General Hospital (Former 307th Hospital of the PLA), Beijing, China.
Xing ChenEndoscopy Center, Shanxi Cancer Hospital, Taiyuan, China.
Haihua ChenEndoscopy Center, Shanxi Cancer Hospital, Taiyuan, China.
Shutang HanJiangsu Province Hospital of TCM and Affiliated Hospital of Nanjing University of TCM, Nanjing, China.
Jun XiaoJiangsu Province Hospital of TCM and Affiliated Hospital of Nanjing University of TCM, Nanjing, China.
Yalei WangThe First Affiliated Hospital of Anhui Medical University, Hefei, China.
Wei HanThe First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yapi LuDepartment of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.
Shuntian CaiDepartment of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.
Weiqing ChenChongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, China.
Wen JiChongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, China.
Xuhua XiaoAffiliated Hospital of Guilin Medical University, Guilin, China.
Qinghua ZhengAffiliated Hospital of Guilin Medical University, Guilin, China.
Beiping ZhangGuangdong Provincial TCM Hospital, Guangzhou, China.
Wenbin WuGuangdong Provincial TCM Hospital, Guangzhou, China.
Guanghui LianGastroenterology Department of Xiangya Hospital, CSU, Changsha, China.
Xiaowei LiuGastroenterology Department of Xiangya Hospital, CSU, Changsha, China.
Qiu ZhaoZhongnan Hospital of Wuhan University, Wuhan, China.
Min ChenZhongnan Hospital of Wuhan University, Wuhan, China.
Kun ZhuangXi'an Central Hospital, Xi'an, China.
Wangli SiXi'an Central Hospital, Xi'an, China.
Xingang ShiDepartment of Gastroenterology, Changhai Hospital, The Second Military University, Shanghai, China.
Youxiang ChenThe First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhaoshen LiDepartment of Gastroenterology, Changhai Hospital, The Second Military University, Shanghai, China.
Dong WangDepartment of Gastroenterology, Changhai Hospital, The Second Military University, Shanghai, China. dongwang0901@sina.com.
Second Military Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CNFirst Hospital of Xi'an · CNGuangdong Provincial Hospital of Traditional Chinese Medicine · CNGuilin Medical University · CNJiangsu Province Hospital · CNNanchang University · CNShanxi Provincial Cancer Hospital · CNZhejiang University · CNZhongnan Hospital of Wuhan University · CNZhongshan Hospital of Xiamen University · CN307th Hospital of Chinese People’s Liberation Army · CNChanghai Hospital · CNChinese PLA General Hospital · CNChongqing Cancer Hospital · CNChongqing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly diagnosis of gastric cancer is difficult in China due to the lack of a valid method for endoscopic screening. Early gastric cancer, especially flat gastric cancer, lacks specific endoscopic features. Many cases appear to be similar to ordinary gastritis cases under normal white light endoscopy, which can lead to misdiagnosis.

aimsIn order to find a new method to improve detection rate of early gastric cancer in China, we designed a trial to validate linked color imaging (LCI) for screening of early gastric cancer in a high-risk population, as compared to white light imaging (WLI).

methodSubjects were randomly allocated to either the LCI + WLI or WLI group and then subjected to gastroscopy and all endoscopies were made after special preparation. All endoscopists had knowledge of this experiment. The main indicator was the rate of detection of gastric neoplastic lesions. The difference in the detection rate between the two groups is reported.

resultsThe detection rate was 4.31% in the WLI group and 8.01% in the LCI + WLI group. This is a difference of 3.70% with a P value < 0.001 and an OR (95% CI) of 1.934 (1.362, 2.746). The lower limit of the 95% CI was greater than 0, and the superiority margin was 1%.

conclusionThe detection rate of gastric neoplastic lesions was higher in the LCI + WLI group than in the WLI group, LCI might be an effective method for screening early gastric cancer.

Indexed as

ChinaEarly Detection of CancerFemaleGastroscopyHumansImage EnhancementMaleMiddle AgedPopulation SurveillanceProspective StudiesRisk FactorsStomach NeoplasmsEarly gastric cancerEndoscopyHigh-risk populationLinked color imagingScreening

Identifiers

PMID32363529
OpenAlexW3022339031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.